|[May 15, 2013]
PHT Corporation Hosts Upcoming Educational Webinar, "Effective Use of Electronic Patient Reported Outcomes (ePRO) in Migraine and Headache Patient Populations"
BOSTON, Mass. and GENEVA, Switzerland --(Business Wire)--
Senior Scientific Advisors Dr. Susan M. Dallabrida and Dr. Jill Platko
Consulting Services will conduct a new webinar, "Effective
Use of Electronic Patient Reported Outcomes (ePRO) in Migraine and
Headache Patient Populations," June 12, at 10-11am and 2-3pm EDT. PHT
is the leading provider of innovative technology systems used to collect patient-driven
eData for clinical research.
The webinar is designed for professionals involved in Protocol
Development, Regulatory Affairs, Health Outcomes, Clinical Operations,
Medical Affairs, Data Management, and CNS.
Migraine and headache patient diary compliance is an important component
for obtaining accurate and high-quality clinical research data. Patient
reported outcome (PRO) and electronic
PRO (ePRO) measures are standard tools for directly eliciing the
patient experience for Clinical Outcome Assessments (COAs). The 2009 FDA
Guidance for Industry Patient Reported Outcome Measures: Use in Medical
Product Development to Support Label Claims highlights
the importance of PROs and other Clinical Outcome Assessment (COAs) in
PRO and ePRO are increasingly becoming an important part of migraine and
headache clinical trials especially with regard to collecting
information around migraine/headache frequency, duration, and severity.
The electronic diary can be used as a daily record of migraines and
headaches in prophylactic treatment studies or used to measure the
effect of a treatment at distinct intervals after study drug
administration in episodic treatment studies.
The webinar will focus on the current use of COAs in migraine and
headache studies, including review of:
Published papers comparing electronic to paper data collection;
Patient compliance with assessments in treatment compared to other
therapeutic areas; and,
Patient compliance of PRO/ePRO assessments to determine the
appropriate frequency of administration for electronic diaries to
obtain accurate and high-quality clinical trial data.
Register at http://bit.ly/13iP670
Dr. Susan Dallabrida has 20+ years of experience in clinical trial
design, strategy, and research and product development in a wide range
of therapeutic areas. She is an experienced senior scientist and project
leader in R&D and has led multiple cross-functional drug discovery and
product development teams and collaborations. Dr. Dallabrida has 20
peer-reviewed articles, 14 grants, 3 patents, 22 abstracts, 31
conference presentations, and 17 awards. She received a B.A. in
Chemistry and a B.S. in Biology, both cum laude, from Bloomsburg
University; and a Ph.D. in Biochemistry and Molecular Biology from
Pennsylvania State University.
Dr. Jill Platko is an expert in laboratory information system management
and clinical research systems with more than 16 years of advanced
training in molecular biology at Cornell University, Genome Therapeutics
Corporation, Whitehead Institute Center for Genome Research and Harvard
Medical School. She provides scientific guidance and review of all
clinical trial protocols to determine ePRO data collection design and
project complexities; and creates demonstration versions of software
customized for each sponsor's clinical trial protocol.
About PHT Consulting Services
The PHT Consulting Services Team has more than 60 years of collective
experience in ePROs and COAs. The Team facilitates biopharmaceutical
researchers and clinicians to implement optimal ePRO/COA trial design
strategies to ensure the success of drug development programs. PHT
consults on all aspects of collecting COAs, with scientific, regulatory,
data management and health outcome expertise.
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical
trial programs with greater confidence, ease and accuracy. Proven PHT
eCOA (electronic Clinical Outcome Assessment) Systems collect
patient-driven eData via smartphones, tablets and the web. This data,
available via the PHT StudyWorks™
online portal, provides sponsors and clinicians with a real time window
into how patients feel and function. PHT has helped trial sponsors
collect patient-driven eData in 600+ global trials resulting in 16
regulatory approvals. PHT offers the regulatory, technological, and
scientific expertise today's market demands and patients deserve. Visit www.phtcorp.com
for more information on PHT. Follow PHT on LinkedIn, Twitter and YouTube (News - Alert).
[ Back To TMCnet.com's Homepage ]